Jazz Pharmaceuticals plc
JAZZ · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $7,615,350 | $7,784,793 | $9,963,088 | $7,605,016 |
| - Cash | $2,412,864 | $1,506,310 | $881,482 | $591,448 |
| + Debt | $6,162,357 | $5,791,614 | $5,812,117 | $6,152,906 |
| Enterprise Value | $11,364,843 | $12,070,097 | $14,893,723 | $13,166,474 |
| Revenue | $4,068,950 | $3,834,204 | $3,659,374 | $3,094,238 |
| % Growth | 6.1% | 4.8% | 18.3% | – |
| Gross Profit | $3,623,237 | $3,398,627 | $3,118,857 | $2,653,478 |
| % Margin | 89% | 88.6% | 85.2% | 85.8% |
| EBITDA | $1,521,711 | $1,449,422 | $1,468,615 | $1,027,746 |
| % Margin | 37.4% | 37.8% | 40.1% | 33.2% |
| Net Income | $560,120 | $414,832 | -$224,060 | -$328,954 |
| % Margin | 13.8% | 10.8% | -6.1% | -10.6% |
| EPS Diluted | 8.65 | 6.1 | -3.58 | -5.51 |
| % Growth | 41.8% | 270.4% | 35% | – |
| Operating Cash Flow | $1,395,908 | $1,092,007 | $1,271,977 | $778,507 |
| Capital Expenditures | -$48,070 | -$23,962 | -$498,194 | -$45,532 |
| Free Cash Flow | $1,347,838 | $1,068,045 | $773,783 | $732,975 |